0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Cutting Edge: Challenges in Medical and Surgical Therapies |

Treatment of Recurrent Aphthous Stomatitis With Fumaric Acid Esters

Emmanuella Guenova, MD; Wolfram Hoetzenecker, MD, PhD
Arch Dermatol. 2011;147(3):282-284. doi:10.1001/archdermatol.2011.27.
Text Size: A A A
Published online

Extract

REFERENCES
Scully  CPorter  S Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 2008;46 (3) 198- 206
PubMed Link to Article[[XSLOpenURL/10.1016/j.bjoms.2007.07.201]]
Femiano  FLanza  ABuonaiuto  C  et al.  Guidelines for diagnosis and management of aphthous stomatitis. Pediatr Infect Dis J 2007;26 (8) 728- 732
PubMed Link to Article[[XSLOpenURL/10.1097/INF.0b013e31806215f9]]
Porter  SScully  C Aphthous ulcers (recurrent). Clin Evid June2005; (13) 1687- 1694
PubMed
Matthews  RWScully  CMLevers  BGHislop  WS Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1987;63 (2) 189- 191
PubMed Link to Article[[XSLOpenURL/10.1016/0030-4220(87)90310-0]]
Greer  RO  JrLindenmuth  JEJuarez  TKhandwala  A A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993;51 (3) 243- 249
PubMed Link to Article[[XSLOpenURL/10.1016/S0278-2391(10)80164-8]]
Hunter  LAddy  M Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo-controlled cross-over trial. Br Dent J 1987;162 (3) 106- 110
PubMed Link to Article[[XSLOpenURL/10.1038/sj.bdj.4806042]]
Skaare  ABHerlofson  BBBarkvoll  P Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). J Clin Periodontol 1996;23 (8) 778- 781
PubMed Link to Article[[XSLOpenURL/10.1111/cpe.1996.23.issue-8]]
Guggenheimer  JBrightman  VJShip  II Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double-blind controlled trial. J Oral Ther Pharmacol 1968;4 (5) 406- 408
PubMed
Stanley  HR Management of patients with persistent recurrent aphthous stomatitis and Sutton's disease. Oral Surg Oral Med Oral Pathol 1973;35 (2) 174- 179
PubMed Link to Article[[XSLOpenURL/10.1016/0030-4220(73)90282-X]]
de Wazières  BGil  HMagy  NBerthier  SVuitton  DADupond  JL Treatment of recurrent ulceration with low doses of thalidomide: pilot study in 17 patients [in French]. Rev Med Interne 1999;20 (7) 567- 570
PubMed Link to Article[[XSLOpenURL/10.1016/S0248-8663(99)80105-2]]
Handfield-Jones  SAllen  BRLittlewood  SM Dapsone use with oral-genital ulcers. Br J Dermatol 1985;113 (4) 501
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.1985.113.issue-4]]
Chandrasekhar  JLiem  AACox  NHPaterson  AW Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87 (5) 564- 567
PubMed Link to Article[[XSLOpenURL/10.1016/S1079-2104(99)70134-4]]
Ruah  CBStram  JRChasin  WD Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 1988;114 (6) 671- 675
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.1988.01860180085037]]
Lehner  TWilton  JMIvanyi  L Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lancet 1976;2 (7992) 926- 929
PubMed Link to Article[[XSLOpenURL/10.1016/S0140-6736(76)90891-6]]
Boras  VVLukac  JBrailo  VPicek  PKordić  DZilić  IA Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration. J Oral Pathol Med 2006;35 (4) 241- 243
PubMed Link to Article[[XSLOpenURL/10.1111/jop.2006.35.issue-4]]
Borra  RCAndrade  PMSilva  ID  et al.  The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med 2004;33 (3) 140- 146
PubMed Link to Article[[XSLOpenURL/10.1111/j.0904-2512.2004.00089.x]]
Mrowietz  UChristophers  EAltmeyer  P Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German Multicentre Study. Br J Dermatol 1998;138 (3) 456- 460
PubMed Link to Article[[XSLOpenURL/10.1046/j.1365-2133.1998.02124.x]]
Lehmann  JCListopad  JJRentzsch  CU  et al.  Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007;127 (4) 835- 845
PubMed Link to Article[[XSLOpenURL/10.1038/sj.jid.5700686]]
Rostami Yazdi  MMrowietz  U Fumaric acid esters. Clin Dermatol 2008;26 (5) 522- 526
PubMed Link to Article[[XSLOpenURL/10.1016/j.clindermatol.2008.07.001]]
Brewer  LRogers  S Fumaric acid esters in the management of severe psoriasis. Clin Exp Dermatol 2007;32 (3) 246- 249
PubMed Link to Article[[XSLOpenURL/10.1111/ced.2007.32.issue-3]]
Hoefnagel  JJThio  HBWillemze  RBouwes Bavinck  JN Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003;149 (2) 363- 369
PubMed Link to Article[[XSLOpenURL/10.1046/j.1365-2133.2003.05433.x]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure

Patient's floor of mouth before (A) and 5 months after (B) treatment with fumaric acid esters.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

146 Views
4 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles
Jobs
brightcove.createExperiences();